Repurposing of N-Acetylcysteine for the Treatment of Dengue Virus-Induced Acute Liver Failure
Gebrehiwot Gebremedhin Tafere, Dawit Zewdu Wondafrash, Filmon Beyenne Demoz Department of Pharmacology and Toxicology, School of Pharmacy, Mekelle University, Mekelle, EthiopiaCorrespondence: Gebrehiwot Gebremedhin Tafere P.O. Box: 1871, Mekelle, EthiopiaTel +251-908822323Email gebrehiwotg07@gmail.c...
Guardado en:
Autores principales: | Tafere GG, Wondafrash DZ, Demoz FB |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fa38bf51a8684854bffacfb764ddbbb5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development and validation of a dynamic survival prediction model for patients with acute-on-chronic liver failure
por: Ben F.J. Goudsmit, et al.
Publicado: (2021) -
Acute Liver Failure due to Hepatitis A Virus
por: Reem Shammout, et al.
Publicado: (2021) -
Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure
por: Annarein J.C. Kerbert, et al.
Publicado: (2021) -
Comparison of extracorporeal cellular therapy (ELAD®) vs standard of care in a randomized controlled clinical trial in treating Chinese subjects with acute-on-chronic liver failure
por: Duan Z, et al.
Publicado: (2018) -
Copeptin as a novel marker predicting prognosis of liver cirrhosis and its major complications
por: Tawfik AK, et al.
Publicado: (2018)